As populations age and diabetes rates rise across Asia Pacific, the risk of preventable vision loss is increasing – placing pressure on individuals, families, and health systems. That's why APVRS and Roche joined forces to host the “Turning Insights into Action: Advancing Vision Health in Asia Pacific” webinar – a multi-stakeholder discussion focused on strengthening early detection, timely treatment, and integrated vision care across the region. Drawing on findings from the APAC Vision Health Survey, experts shared lived experiences and perspectives from diverse healthcare settings, highlighting the importance of collaborative approaches to protecting vision and improving outcomes. Watch the full discussion here: https://lnkd.in/ek3K2Ah3 #APVRS #APACVisionHealthSurvey #RocheOphthaAPAC #RocheOphthalmology Andrew Chang Mårten Brelén Nor Fariza Ngah Paisan Ruamviboonsuk Prof Seung Young Yu Ahmed Elhusseiny
Info
Roche ist ein globales Unternehmen mit Vorreiterrolle in der Erforschung und Entwicklung von Medikamenten und Diagnostika und ist darauf fokussiert, Menschen durch wissenschaftlichen Fortschritt ein besseres, längeres Leben zu ermöglichen. Dank der Kombination von Pharma und Diagnostika unter einem Dach ist Roche führend in der personalisierten Medizin - einer Strategie mit dem Ziel, jeder Patientin und jedem Patienten die bestmögliche Behandlung zukommen zu lassen. Roche ist das grösste Biotech-Unternehmen weltweit mit differenzierten Medikamenten für die Onkologie, Immunologie, Infektionskrankheiten, Augenheilkunde und Erkrankungen des Zentralnervensystems. Roche ist auch der bedeutendste Anbieter von In-vitro-Diagnostika und gewebebasierten Krebstests und ein Pionier im Diabetesmanagement. Seit der Gründung im Jahr 1896 erforscht Roche bessere Wege, um Krankheiten zu verhindern, zu erkennen und zu behandeln und leistet einen nachhaltigen Beitrag zur gesellschaftlichen Entwicklung. Zum Ziel des Unternehmens gehört es durch Kooperationen mit allen relevanten Partnern den Zugang von Patienten zu medizinischen Innovationen zu verbessern. Auf der Liste der unentbehrlichen Arzneimittel der Weltgesundheitsorganisation stehen heute 30 von Roche entwickelte Medikamente, darunter lebensrettende Antibiotika, Malariamittel und Krebsmedikamente. Ausgezeichnet wurde Roche zudem bereits das neunte Jahr in Folge als das nachhaltigste Unternehmen innerhalb der Pharma-, Biotechnologie- und Life-Sciences-Branche im Dow Jones Sustainability Index. Die Roche-Gruppe mit Hauptsitz in Basel, Schweiz ist in über 100 Ländern tätig und beschäftigte 2017 weltweit rund 94 000 Mitarbeiterinnen und Mitarbeiter. Im Jahr 2017 investierte Roche CHF 10,4 Milliarden in Forschung und Entwicklung und erzielte einen Umsatz von CHF 53,3 Milliarden. Genentech in den USA gehört vollständig zur Roche-Gruppe. Roche ist Mehrheitsaktionär von Chugai Pharmaceutical, Japan. Weitere Informationen finden Sie unter www.roche.com/careers #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalizedHealthcare #GreatPlaceToWork #Innovation
- Website
-
http://www.roche.com/
Externer Link zu Roche
- Branche
- Biotechnologieforschung
- Größe
- 10.001+ Beschäftigte
- Hauptsitz
- Switzerland 🇨🇭
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Spezialgebiete
- biotechnology, innovation, personalized healthcare, great place to work, diagnostics, pharmaceuticals, research, healthcare, personalised healthcare, diabetes care, genomics, healthcare technology, big data und Science
Orte
Beschäftigte von Roche
Updates
-
Mass spectrometry has the potential to provide patients with more personalised diagnoses. But do you know what makes this technology a gold standard in clinical diagnostic testing? #massspectrometry #innovation #diagnostics #RocheMassSpec
Dieser Inhalt ist hier nicht verfügbar.
Mit der LinkedIn App können Sie auf diese und weitere Inhalte zugreifen.
-
Graduation season is a truly meaningful moment at Roche - seeing our talent grow and step into what’s next is inspiring. Together with our CEO Thomas Schinecker, we’re proud to celebrate 44 apprentices as they begin a new chapter. Join us in celebrating new beginnings, ongoing growth and staying curious. #WeAreRoche #GrowthMindset #EarlyCareers #Career
CEO Roche Group | Passionate about science, and committed to positively impacting people’s lives through healthcare
Just as the UEFA Women's EURO 2025 kicked off here in Switzerland, we were celebrating another kind of kickoff: a new chapter in many professional journeys. Last week, I joined 44 Roche apprentices to celebrate their graduation. Moments like these are among the most meaningful in any career – because they remind us where it all begins. I told our graduates: You don’t need to have it all mapped out. But one thing is clear – there are no shortcuts in life. If you want to achieve something, the only way to get there is through hard work and dedication. Football is a good reminder of many things: Teamwork matters. Preparation matters. Continuous learning and improvement matters. Last but not least, as a famous coach once said: “Nach dem Spiel ist vor dem Spiel.” In life – just like in football – you can’t rest on past successes. There’s always a next challenge. At Roche, we are investing in the next generation. Not just because it’s the right thing to do, but because we learn from them, too. They challenge how we do things. And they remind us to stay curious. More than half of this year’s apprentices will stay on at Roche – some as employees, others as students. That says a lot. About them, and about the people who guided them along the way. To all those finishing their training this summer – and to everyone who supported them: Congratulations – and thank you. Enjoy the moment!
-
-
What happens when young artists and scientists team up to build the future? 💡 We're about to find out! Next week, between July 13 and 19, Roche Continents 2025 brings together 40 of Europe’s brightest young minds to Arles, France, for a week of intense exploration and innovation. For over a decade, this program has united students from science and the arts to uncover where transformative ideas truly come from. This year's "Futurescapes" theme will challenge them to focus on sustainable development, ethical considerations, and the human experience within an evolving world. In partnership with LUMA Arles, participants will dive into hands-on workshops and interdisciplinary collaboration, creating solutions that drive positive change. Learn more about how we're empowering young minds to shape the future: https://lnkd.in/dEa4K9ZV #RocheContinents2025 #Futurescapes #Art #Science #Innovation
-
According to the UN World Population Prospects, the average life expectancy at birth in Europe is projected to increase from 79.5 years in 2025 to 84 years by 2050, with more people reaching the age of 100. But will those extra years be healthy? 🤔 New research commissioned by Roche and conducted by GWI reveals growing concerns about access to quality healthcare as populations age, making it a top public priority. The report also explores how innovation can play a key role in addressing these challenges. 📄 Discover more in our latest Insight Report below: 👇 #TheEraOfLongevity #HealthcareInnovation #FutureOfEurope #AgingPopulation
-
We're proud to renew our partnership with The Global Fund and extend our collaboration to enhance countries' diagnostics capacities to advance progress in waste management and the global fight against infectious disease. Over the last years, we have combined our expertise, resources, solution and networks to address systemic gaps preventing people living in low-and-middle income countries from accessing essential diagnostics services. Join us as we empower communities and health systems in achieving equitable access to care. Learn more about our journey: https://lnkd.in/dPUgAwH2 #AccessPartnerships #GlobalHealth
-
-
Our Chief Medical Officer Levi Garraway recently shared his career journey – shaped by personal experiences and a commitment to bridging the gap between scientific discovery and clinical care – with OncoDaily. He reflected on the people who have inspired him along the way and the discoveries that led him from the lab to co-founding the precision cancer company Foundation Medicine. He also shared his advice with early career scientists and physicians. Find more here https://spkl.io/6044A6pDw
-
-
Diagnostics help people live better, longer and healthier lives. Integrating diagnostic breakthroughs within the lab enables real impact, helping patients on their diagnostic journeys and transforming routine care. Enter a new dimension in mass spectrometry. https://lnkd.in/dmszaUwc #massspectrometry #innovation #diagnostics #RocheMassSpec
-
"At Youth Off The Streets — we transform despair into hope." This powerful statement from Peta Gillis moved us into action at Roche. While the reality of youth homelessness is often unseen, its impact is profound. Of the 43,226 young people who presented alone for homelessness support last year, half were turned away. We believe that every step counts in addressing these challenges. Today, our Roche Australia and Roche Diagnostics Australia teams are lacing up for the annual Roche Children’s Walk, to support Youth Off the Streets, an organisation dedicated to empowering children and young people experiencing disadvantage in Australia. A heartfelt thank you to everyone in Australia who stepped up to fundraise with such passion! To extend the impact of our walk, Roche will match all local funds raised. These donations will support our charity partners around the world, including Child’s Dream, UNICEF, Selam Children’s Village, Roger Federer Foundation, and ActionAid. The Roche Children’s Walk is an annual global event that has been running since 2003. The funds we raise support both global and local charities, all dedicated to improving education, nutrition, primary healthcare, and social development for children worldwide. At Roche, we are striding towards a better future for the next generation, one step at a time. #OneRocheAustralia #WalkingWithAPurpose #WeAreRoche #RocheAustralia #RocheDiagnosticsAustralia #RocheChildrensWalk #RocheGivesBack #RocheAPAC Nic Horridge Anand Vairavan
-
-
-
-
-
+15
-
-
News from the Global Cervical Cancer Elimination Forum! 🎉 Roche is expanding affordable pricing for HPV DNA tests to 17 more low and middle-income countries, now reaching 106 nations. This means up to 50 million more women could gain access to essential, affordable HPV screening. Together with the WHO, Unitaid, and various Ministries of Health, we're helping to strengthen health systems and ensure access to vital screenings. Let’s keep working together to close the screening gap and move closer to a world without cervical cancer. See an example of how collaboration can help get more women screened: https://lnkd.in/gbGa7SkV #CervicalCancerElimination #GlobalHealth #healthcare
-
Verbundene Seiten
Ähnliche Seiten
Finanzierung
Letzte Runde
Kapitalerhöhung nach Börsengang5.000.000.000,00 $
Investor:innen